Weight Management
GLP-1 Weight Loss Programs: What Medically Supervised Care Includes
A medically supervised GLP-1 program covers evaluation, candidacy, dosing, side effect management, monitoring, and maintenance. Here is what that care actually includes at the Columbia, Maryland clinic.
Reviewed by the clinical team at Zest 4 Wellness · September 19, 2026 · 8 min read
A medically supervised GLP-1 weight loss program begins with an evaluation and lab review, prescribes an FDA-approved medication only when a patient meets the criteria, manages dose titration and side effects, monitors safety markers, and includes a maintenance plan so progress is not lost when the medication is stopped. At Zest 4 Wellness in Columbia, Maryland, this happens under physician supervision with follow-up visits built into the program, not sold as a standalone prescription order.
What GLP-1 medications are
GLP-1 receptor agonists are a class of prescription medications that work along the body's appetite and blood sugar pathways. Three agents are FDA-approved for chronic weight management in adults: liraglutide 3.0 mg (Saxenda, approved 2014), semaglutide 2.4 mg (Wegovy, approved 2021), and tirzepatide (Zepbound, approved 2023). Eligibility centers on a body mass index (BMI) of 30 or higher, or a BMI of 27 or higher with at least one weight-related medical condition. Every one of these medications is approved as an adjunct to a reduced-calorie diet and increased physical activity, not as a replacement for them.
What a supervised program includes
- A medical evaluation and baseline labs review your history, medications, and health markers before any decision.
- Candidacy is checked against current prescribing criteria, including BMI and weight-related conditions, and any contraindications are identified.
- When appropriate, a specific medication, starting dose, and titration schedule are prescribed with clear instructions.
- Side effects are reviewed and managed, including how to handle nausea or digestive symptoms during dose increases.
- Safety monitoring includes scheduled follow-up visits and repeat labs, since serious but uncommon risks such as pancreatitis or gallbladder disease require ongoing review.
- A maintenance plan covers nutrition, activity, behavioral support, and what happens if the medication is paused or stopped.
Common side effects and serious risks
The most common side effects are gastrointestinal: nausea, diarrhea, vomiting, constipation, and abdominal pain, especially early in treatment or as the dose increases. Most settle with slow titration and guidance. Serious risks that require physician oversight include pancreatitis, gallbladder disease, kidney injury, and severe gastrointestinal reactions. The FDA labels for these medications also carry a boxed warning about a rare type of thyroid tumor seen in animal studies, so personal and family history are reviewed carefully before prescribing.
The caution about compounded versions
Because demand for these medications rose quickly, compounded versions appeared widely. When the original drugs are not in shortage, federal guidance has ended the temporary allowance for large-scale compounding of them, and regulatory action has targeted continuing sales. Compounded products are not held to the same manufacturing standards as FDA-approved drugs, so patients should verify the source and supervision of anything they are prescribed. A responsible program prescribes and sources medications carefully rather than defaulting to compounded product.
| Program step | What happens |
|---|---|
| Evaluation | History, exam, and baseline labs |
| Candidacy review | BMI, weight-related conditions, contraindications |
| Prescription and titration | FDA-approved medication, starting dose, escalation plan |
| Side effect management | Guidance for nausea and digestive symptoms; dose adjustments |
| Monitoring | Follow-up visits and repeat labs over the treatment course |
| Maintenance | Plan for nutrition, activity, and life after the medication |
Why supervision matters
Medications that change appetite and digestion are powerful tools, and they come with real risks. When therapy is stopped, appetite often returns, and without a structured plan some regained weight is common. The value of a clinic-based program is that the prescription is only one part of a system built around your labs, your follow-up, and your long-term health rather than a shipping label.
See how GLP-1 weight loss programs work at the Columbia clinic (/services/glp-1-weight-loss/).
Read about why weight can stay stuck despite effort (/blog/why-am-i-not-losing-weight/).
Sources & further reading
- FDA Press Announcement: FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014 (Wegovy)
- FDA Press Announcement: FDA Approves New Medication for Chronic Weight Management (Zepbound)
- FDA: FDA Approves Weight Management Drug for Patients Aged 12 and Older (Saxenda)
- NIDDK: Prescription Medications to Treat Overweight and Obesity
- FDA Label: WEGOVY (semaglutide) Injection (side effects and warnings)
Next step
If you are curious whether a GLP-1 program fits your situation, the first step is a medical conversation, not a dosage calculator. Book a free 15-minute consultation at the Columbia, Maryland clinic and a member of our clinical team will review your history and explain what supervised weight loss support involves.
Talk with our care team about this topic
A member of our clinical team can answer your questions at the Columbia, Maryland clinic. If GLP-1 Weight Loss Programs may be appropriate for you, the first step is a consultation.
Care at Zest 4 Wellness is physician-guided. Meet Dr. Francisco Ward, who evaluates patients at the Columbia, Maryland clinic.